Replies to post #90588 on US Stem Cell Inc (USRM)

[Afterhoursearnings3]

I will be beyong pleased with 3-4 million in revs for the year. 4mil(revs)*10(multiple)/357mil(float)=.11 per share true value. Now that is assuming no growth. 10 is a lower end multiple. For rapid growth like stem cell field is seeing 20 or 30 is more reasonable. Check out some of the tech multiples! I think .33 a share is a good value for what USRM can bring to the table for any company wanting to buy us out. And .11 a share (low end) is still a 50% premium to current prices!